Literature DB >> 6262247

Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera.

R Eberle, R J Courtney.   

Abstract

A reliable and reproducible method for determining specific reactivity to herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in human sera has been developed. Human sera were used to immunoprecipitate HSV-specific glycoprotein antigens from both HSV-1- and HSV-2-infected cell extracts. The viral glycoproteins precipitated from these extracts were then analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to detect specific reactivity of the sera with distinct type-specific antigens of HSV-1, HSV-2, or both as well as with type-common glycoprotein antigens. By examining a large number of human sera, this method was found to be more reliable than the standard microneutralization test in discriminating between single-positive (positive for HSV-1 or HSV-2) and double-positive (positive for HSV-1 and HSV-2) sera.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262247      PMCID: PMC351425          DOI: 10.1128/iai.31.3.1062-1070.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

Review 2.  A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.

Authors:  G Plummer
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

3.  Surface glycopeptides in the envelope of herpes simplex virions.

Authors:  U Olshevsky; Y Becker
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

4.  Measurement of antibodies to herpesvirus types 1 and 2 in human sera.

Authors:  W E Rawls; K Iwamoto; E Adam; J L Melnick
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

5.  Antibodies to Herpesvirus hominis types 1 and 2 in the rabbit.

Authors:  A J Nahmias; W R Dowdle; J H Kramer; C F Luce; S C Mansour
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

6.  A serologic study of herpesvirus hominis strains by microneutralization tests.

Authors:  F P Pauls; W R Dowdle
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

7.  Antibodies to type 1 and type 2 herpes virus in women with abnormal cervical cytology.

Authors:  G R Skinner; M E Thouless; J A Jordan
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-11

8.  gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide.

Authors:  R Eberle; R J Courtney
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

9.  Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women.

Authors:  J W Smith; S P Lowry; J L Melnick; W E Rawls
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

10.  Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.

Authors:  A Hollinshead; O B Lee; W McKelway; J L Melnick; W E Rawls
Journal:  Proc Soc Exp Biol Med       Date:  1972-11
View more
  18 in total

1.  Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot.

Authors:  J Dalessio; R Ashley
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies.

Authors:  D E Goade; R Bell; T Yamada; G J Mertz; S Jenison
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.

Authors:  C H Sherlock; R L Ashley; M L Shurtleff; K D Mack; L Corey
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

4.  Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens.

Authors:  B Svennerholm; S Olofsson; S Jeansson; A Vahlne; E Lycke
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

5.  Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.

Authors:  J Glorioso; C H Schröder; G Kumel; M Szczesiul; M Levine
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

6.  Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.

Authors:  D W Ho; P R Field; W L Irving; D R Packham; A L Cunningham
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.

Authors:  E M Cantin; R Eberle; J L Baldick; B Moss; D E Willey; A L Notkins; H Openshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.

Authors:  L Pereira; M Hoffman; N Cremer
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Extensive homology between the herpes simplex virus type 2 glycoprotein F gene and the herpes simplex virus type 1 glycoprotein C gene.

Authors:  D J Dowbenko; L A Lasky
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.

Authors:  K E Dolter; W F Goins; M Levine; J C Glorioso
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.